Very few studies with objective information about the incidence, clinical characteristics, and consequences of a new COVID- 19 disease in children have been published so far. Early evidence suggests that coronavirus infection is less harmful to children than to adults. There are still many questions related to the effects of SARS-CoV-2 on children with coinfection (RSV, rhinovirus, bokavirus, and adenovirus) and comorbidities (bronchial asthma, congenital heart defects, and diabetes mellitus). Even several studies will help to identify the main effects of coronavirus on the child’s organism and consequences of the disease, as well as to predict possible disorders and develop a rehabilitation strategy for such patients. We suggest using novel methods of medical rehabilitation with proven effectiveness in children with bronchopulmonary disorders associated with coronavirus infection.